The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology
Year: 2016
Type: article
Abstract: Medicare & Medicaid Innovation (CMMI) and private payers as they seek better ways to incentivize and support high-quality, high-value patient care.• Congress should aggressively monitor implementation of MACRA to ensure (1) that the Administration works with professional organizations to test multiple payment models of care and (2) the Administration provides a clear path for implementation of payment models shown to provide positive results for patients, providers, and payers.Advance health information technology that supports efficient, coordinated care across the cancer care continuum.• Congress should require that health information technology vendors create products that promote interoperability.• Policymakers should ensure that patients with cancer, oncologists, and other oncology providers do not bear the cost of achieving interoperable EHRs and that companies refrain from information blocking.• Professional organizations and other stakeholders should work with federal officials to ensure that health care providers have the information necessary to be prudent purchasers and users of health information technology systems.Recognize and address the unsustainable trend in the cost of cancer care.• Congress should work with stakeholders to pursue solutions that will curb unsustainable costs for patients, providers, and the health care system.• Payers should design payment systems that incentivize patient-centered, high-value care and invest in infrastructure that supports a viable care delivery system.• Professional organizations should develop and disseminate clinical guidelines, tools, and resources such as Choosing Wisely to optimize patient care, reduce waste, and avoid inappropriate treatment.• Professional organizations should promote shared decision making between patients and physicians and the development of high-value treatment plans consistent with patients' needs, values, and preferences.ASCO will continue to: (1) track and evaluate the evershifting landscape in cancer care over the coming year, (2) support cancer care providers as they negotiate these growing pressures, and (3) work with policymakers to ensure that changes in the system support access to high-quality, highvalue care for all patients.
Source: Journal of Oncology Practice
Author: American Society of Clinical Oncology
Institution: American Society of Clinical Oncology
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W4239502937